NGVT Ingevity Corporation

NGVT's shares rally as portfolio optimization, capacity investments and debt reduction boost confidence in long-term growth prospects.

Ingevity (NYSE:NGVT) is nearing completion of a strategic portfolio transformation that has narrowed its focus to its Performance Materials and Pavement Technologies businesses, President and Chief Executive Officer David Li said during a Water Tower Research conference session. Li, who became CEO

Ingevity (NGVT) is back on investor calendars ahead of its appearance at the Water Tower Research Virtual Insights Conference on September 23, 2026, which is drawing attention to the stock’s recent performance profile. Recent trading has been lively, with Ingevity’s share price up 3.35% over the last session and 5.06% over the past week. The 18.61% year to date share price return and 26.97% one year total shareholder return suggest momentum is building despite a weaker 90 day patch. Scan...

Ingevity has delivered a solid multi year run in its share price, which naturally raises a question for anyone looking at the stock today. Is the current market value of Ingevity really in line with what its earnings can support, or has the price moved ahead of the underlying profit engine? Over the past 3 years, Ingevity has returned 51.6%, putting real weight on the question of whether that gain lines up with the business's earnings power. The company’s ability to convert its specialty...

Here is how Ingevity (NGVT) and Solstice Advanced Materials (SOLS) have performed compared to their sector so far this year.

NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.

Hybrid vehicle demand drove margin expansion across all segments.

Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.

Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.

Why Ingevity’s latest earnings and buyback matter for shareholders Ingevity (NGVT) just posted second quarter 2026 results that show higher profitability compared with last year’s loss, alongside lower sales and the completion of a multi year share repurchase program. See our latest analysis for Ingevity. At a share price of $73.11, Ingevity has gained 21.67% on a year-to-date share price basis, while the 1-year total shareholder return of 80.97% points to strong recent momentum despite some...

Ingevity Corporation recently reported past second-quarter 2026 results, with sales of US$314.1 million and net income of US$35.3 million, marking a return to profitability versus a loss a year earlier. Alongside this earnings rebound, Ingevity completed a sizeable share repurchase program totaling 4,381,177 shares for US$289.45 million, retiring about 12.01% of its outstanding stock since 2022. We’ll now examine how this move from loss to profit could influence Ingevity’s investment...

Ingevity (NYSE:NGVT) reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook. Chief Executive Officer and President Dave Li said

Adjusted EBITDA surged nearly 14% with margins expanding to 36.6%, driven by exceptional Performance Materials results and a key PFAS filtration contract win.

Moby summary of Ingevity Corporation's Q2 2026 earnings call

Ingevity (NGVT) delivered earnings and revenue surprises of +32.82% and +4.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ashland (ASH) delivered earnings and revenue surprises of -0.97% and +2.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Green Plains (GPRE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.